Mathematical modeling leads to a better understanding of prostate cancer

by Eva Schissler,University of CologneCredit:Cell Systems(2024). DOI: 10.1016/j.cels.2024.10.005A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine

Updated on: December 01,2024

Mathematical modeling leads to a better understanding of prostate cancer

by Eva Schissler,University of CologneCredit:Cell Systems(2024). DOI: 10.1016/j.cels.2024.10.005A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine

Updated on:December 01,2024

Research concentrates on genes that cause tumors in the Meibomian gland

byTufts UniversityDr. Cornelia Peterson calibrates a piece of equipment used to measure intraocular pressure during an ocular toxicity study in animals. Credit: Noah MossDr. Cornelia Peterson is

Updated on: December 01,2024

Research concentrates on genes that cause tumors in the Meibomian gland

byTufts UniversityDr. Cornelia Peterson calibrates a piece of equipment used to measure intraocular pressure during an ocular toxicity study in animals. Credit: Noah MossDr. Cornelia Peterson is

Updated on:December 01,2024

A new strategy to enhance gene therapy for sickle cell disease

byMary Ann Liebert, IncCyclosporin H Improves the Transduction of CD34+ Cells with an Anti-Sickling Globin Vector, a Possible Therapeutic Approach for Sickle Cell Disease. Credit: Mary Ann Liebe

Updated on: November 22,2024

A new strategy to enhance gene therapy for sickle cell disease

byMary Ann Liebert, IncCyclosporin H Improves the Transduction of CD34+ Cells with an Anti-Sickling Globin Vector, a Possible Therapeutic Approach for Sickle Cell Disease. Credit: Mary Ann Liebe

Updated on:November 22,2024

Overcoming resistance to colon cancer treatment

byUniversity of GenevaColorectal cancer cells after treatment with FOLFOXIRI chemotherapy for 34 weeks. Cell fibers (in green) and nuclei (in blue). Credit: UNIGE-Nowak-SliwinskaColorectal cance

Updated on: December 28,2023

Overcoming resistance to colon cancer treatment

byUniversity of GenevaColorectal cancer cells after treatment with FOLFOXIRI chemotherapy for 34 weeks. Cell fibers (in green) and nuclei (in blue). Credit: UNIGE-Nowak-SliwinskaColorectal cance

Updated on:December 28,2023

Study shows elevated cancer risk for women with endometriosis

byHuntsman Cancer InstituteCredit: CC0 Public DomainA landmark study from researchers at Huntsman Cancer Institute at the University of Utah (the U), the Spencer Fox Eccles School of Medicine at

Updated on: August 03,2024

Study shows elevated cancer risk for women with endometriosis

byHuntsman Cancer InstituteCredit: CC0 Public DomainA landmark study from researchers at Huntsman Cancer Institute at the University of Utah (the U), the Spencer Fox Eccles School of Medicine at

Updated on:August 03,2024

Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment, researchers say

byH. Lee Moffitt Cancer Center & Research InstituteCancer cell during cell division. Credit: National Institutes of HealthThe recent U.S. Food and Drug Administration approval of lifileucel,

Updated on: August 03,2024

Tumor-infiltrating lymphocyte therapy marks a milestone in cancer treatment, researchers say

byH. Lee Moffitt Cancer Center & Research InstituteCancer cell during cell division. Credit: National Institutes of HealthThe recent U.S. Food and Drug Administration approval of lifileucel,

Updated on:August 03,2024

Treatment shown to improve the odds against bone marrow cancer

by Newcastle UniversityCredit: CC0 Public DomainHope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and

Updated on: April 10,2024

Treatment shown to improve the odds against bone marrow cancer

by Newcastle UniversityCredit: CC0 Public DomainHope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and

Updated on:April 10,2024

Researcher recommends tailoring colorectal cancer screening for 45-to-49-year-olds

by Regenstrief InstituteCredit: Pixabay/CC0 Public DomainIt's been a year since national recommendations issued by the American Cancer Society and the U.S. Multi-Society Task Force called for

Updated on: January 30,2024

Researcher recommends tailoring colorectal cancer screening for 45-to-49-year-olds

by Regenstrief InstituteCredit: Pixabay/CC0 Public DomainIt's been a year since national recommendations issued by the American Cancer Society and the U.S. Multi-Society Task Force called for

Updated on:January 30,2024

Pembrolizumab aids survival with high-risk endometrial cancer

by Lori SolomonPembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published onl

Updated on: November 09,2024

Pembrolizumab aids survival with high-risk endometrial cancer

by Lori SolomonPembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published onl

Updated on:November 09,2024

State-of-the-art MRI technology bypasses need for biopsy

by UT Southwestern Medical CenterDr. Ivan Pedrosa, left, and Dr. Jeffrey Cadeddu, right, are co-authors of a study highlighted on the cover of The Journal of Urology on multiparametric MRI (mpMRI

Updated on: March 21,2024

State-of-the-art MRI technology bypasses need for biopsy

by UT Southwestern Medical CenterDr. Ivan Pedrosa, left, and Dr. Jeffrey Cadeddu, right, are co-authors of a study highlighted on the cover of The Journal of Urology on multiparametric MRI (mpMRI

Updated on:March 21,2024

Drug shows promise as immune therapy for cancer

by Ziba Kashef,Yale UniversityNew Yale-led research may offer novel immunotherapies for skin, colon, breast, pancreatic and other cancers. Credit: stock.adobe.comA therapy developed by Yale rese

Updated on: May 25,2024

Drug shows promise as immune therapy for cancer

by Ziba Kashef,Yale UniversityNew Yale-led research may offer novel immunotherapies for skin, colon, breast, pancreatic and other cancers. Credit: stock.adobe.comA therapy developed by Yale rese

Updated on:May 25,2024

New research could prevent jaw damage in patients being treated for cancer or osteoporosis

by Gary Polakovic,University of Southern CaliforniaOsteonecrosis of the jaw is a rare, incurable side effect of some drug treatments. Credit: Photo/Science SourceUSC researchers and collaborator

Updated on: May 21,2024

New research could prevent jaw damage in patients being treated for cancer or osteoporosis

by Gary Polakovic,University of Southern CaliforniaOsteonecrosis of the jaw is a rare, incurable side effect of some drug treatments. Credit: Photo/Science SourceUSC researchers and collaborator

Updated on:May 21,2024